Ebos Group

EBO.ASX

Health Care

Diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products.

Market Data

Price

$16.350

+0.0%
Market Cap

$3.3B

P/E Ratio

14.3x

EPS

$1.365

Div. Yield

5.62%

52-Week Change

-0.4%

Latest Earnings

ASX Appendix 4D

25 February 2026

Revenue
$6,768
+13.0% YoY
NPAT
$125.40
-4.3% YoY
EPS
$0.61
Dividend
$0.57

EBOS Group delivered strong interim results with revenue up 13.0% to $6.77B and statutory NPAT rising 13.3% to $124.8M, though underlying NPAT declined 4.3% to $125.4M due to higher restructuring costs. The company maintained its interim dividend at 57.0 NZ cents, fully franked, with underlying earnings pressured by integration and restructuring activities. Key points: Strong revenue growth of 13.0% to $6.77B driven by business expansion; Statutory NPAT increased 13.3% to $124.8M despite underlying pressures; Maintained interim dividend at 57.0 NZ cents, fully franked

Recent Announcements

22 Apr 2026 Guidance Negative

Impact of elevated fuel costs on FY26 earnings outlook

EBOS Group Limited has lowered its FY26 underlying EBITDA guidance to $610–$620 million from $615–$635 million due to elevated fuel and energy costs that have exceeded prior assumptions, resulting in an estimated $5–10 million impact that cannot be fully passed through to customers due to service continuity requirements and government arrangements. The company is implementing efficiency measures and engaging with stakeholders on fuel cost recovery, though the timing and outcome remain uncertain.

23 Mar 2026 Sph Neutral

Becoming a substantial holder

Accident Compensation Corporation (ACC) became a substantial holder (5.237%).

25 Feb 2026 Actual Results Neutral

ASX Appendix 4D

EBOS Group delivered strong interim results with revenue up 13.0% to $6.77B and statutory NPAT rising 13.3% to $124.8M, though underlying NPAT declined 4.3% to $125.4M due to higher restructuring costs. The company maintained its interim dividend at 57.0 NZ cents, fully franked, with underlying earnings pressured by integration and restructuring activities. Key points: Strong revenue growth of 13.0% to $6.77B driven by business expansion; Statutory NPAT increased 13.3% to $124.8M despite underlying pressures; Maintained interim dividend at 57.0 NZ cents, fully franked

7 Feb 2026 Date Announcement Neutral

Earnings Release - 25 February 2026

Upcoming earnings release expected 25 February 2026 (from Yahoo Finance (confirmed))

22 Jan 2026 Date Announcement Neutral

Advance Notice - Half Year Results

EBOS Group Limited will release its FY26 interim financial results for the half-year ended 31 December 2025 on Wednesday, 25 February 2026, with a live webcast at 11:30am NZDT. The company will also host an Investor Day on 30 April 2026.

Get real-time alerts for EBO

Receive AI-powered earnings summaries and instant notifications when Ebos Group releases results.

Register Free